Patient Home
Welcome to Health Vidya. Discover trusted care and your own health — all in one place.
These highlights do not include all the information needed to use XEOMIN® safely and effectively. See full prescribing information for XEOMIN. XEOMIN (incobotulinumtoxinA) for injection, for intramuscular or intraglandular use Initial U.S. Approval: 2010
Medication labelWhy this: Advisory · dailymed-prescription
XEOMIN is indicated for the treatment of chronic sialorrhea in patients 2 years of age and older. XEOMIN is indicated for the treatment of upper limb spasticity in patients 2 years of age and older. XEOMIN is indicated for the treatment of cervical dystonia in adult patients. XEOMIN is indicated for the treatment of blepharospasm in adult patients. XEOMIN is indicated in adult patients for the temporary improvement in the appearance of upper facial lines: moderate to severe glabellar lines (GL) associated with corrugator and/or procerus muscle activity moderate to severe horizontal forehead lines (HFL) associated with frontalis muscle activity moderate to severe lateral canthal lines (LCL) associated with orbicularis oculi muscle activity.
- generic_name
- incobotulinumtoxina
- product_names
- incobotulinumtoxinA
- ndc
- 0259-1605, 0259-1605-01, 0259-1610, 0259-1610-01, 0259-4150, 0259-4150-01, 0259-4110, 0259-4110-01, 0259-1620, 0259-1620-01, 0259-1620-10
- group
- drugs
- license
- us-gov-pd
- attribution
- Courtesy of the National Library of Medicine
- reviewed
- 2026-09-18
- language
- en